Skip to search formSkip to main contentSkip to account menu

Gemcitabine-Docetaxel Regimen

A regimen consisting of gemcitabine and docetaxel used for the treatment of unresectable soft tissue sarcoma.
National Institutes of Health

Related topics

Related topics

3 relations
Gemcitabine hydrochlorideSarcomadocetaxel

Search for papers about Gemcitabine-Docetaxel Regimen

Search papers
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)